Volume 195 - Issue 11

Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland

Authors:  Sean A Bydder and Nigel A Spry

Med J Aust 2011; 195 (11): 661-662. || doi: 10.5694/mja11.11271
Published online: 12 December 2011

To the Editor: We find ourselves in the curious position of criticising an article that supports improving access to radiotherapy. Baade and colleagues looked at cause-specific survival in all patients aged 20–79 years diagnosed with rectal cancer in Queensland.1 They found a 6% increase in cause-specific mortality risk for each 100 km increment in distance from the nearest radiotherapy facility. They concluded that the apparent poorer outcomes were due to a failure to receive radiotherapy.

However, we suggest that their approach was significantly flawed in a number of ways. We have difficulty in understanding why, when information about the use of radiotherapy is available, this key explanatory factor was not actually measured. The size of the benefit they attribute to greater use of radiotherapy exceeds the expected improvements attributable to adjuvant radiotherapy compared with none at all.2 The authors state that pathological staging, another factor central to their analysis, is a reliable surrogate for clinical staging. However, they appear not to have made any allowance for the fact that neoadjuvant treatment leads to pathological down-staging. Finally, the main outcome, cause-specific survival, was taken from death certificates and is likely to be inaccurate.

Use of radiotherapy is suboptimal in Australia.3 If the authors could identify the impact of distance on access to radiotherapy, this would be very valuable for cancer service planning. Clinical input is desirable in future investigations in this area.


Authors


Competing interests


References


More like this

Cancer Research 18 August 2026 Open Access

Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study

Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See, Gavin M. Wright, David Langton, Thomas John, Matthew Conron, James Bartlett, Nicola Atkin, Nikolajs Zeps, Susan V. Harden, Wasek Faisal, John R. Zalcberg, Rob G. Stirling

Cancer Research 18 August 2026 Open Access

Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning

Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs

Cancer Guideline summary 13 July 2026 Open Access

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia

Nicole M. Rankin, Rebecca Zosel, Lisa J. Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A. R. Lantin, Georgia Bartlett, Mikayla Wolfe, Abbey Diaz, Katrina Anderson, Lillian Liu, Cindy Toms, Sarah McDermott, Peter Bligh, Jeremy Chalke, Stephen Melsom, Claire E. Nightingale, Alison Brown, Sam Pope, Julia Brotherton, Anne Fidler, Michel Itel, Mark Brooke, Diane M. Pascoe, Fraser Brims, Tracy L. Leong, Emily Stone, Dorothy Keefe, Vivienne Milch